▶ 調査レポート

ワクチンアジュバントのグローバル販売市場 2020年

• 英文タイトル:Global Vaccine Adjuvants Sales Market Report 2020
• レポートコード:MRC2102QY15834
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、142ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥528,000 (USD4,000)▷ お問い合わせ
  Multi User¥792,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,056,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のワクチンアジュバント市場について種類別(経口、皮下、筋肉内、その他)、用途別(獣医用ワクチンアジュバント(研究、商業)、ヒト用ワクチンアジュバント(研究、商業))、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ワクチンアジュバント市場の概要
・世界の主要地域別ワクチンアジュバント市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のワクチンアジュバント市場規模2015-2026:種類別(経口、皮下、筋肉内、その他)
・世界のワクチンアジュバント市場規模2015-2026:用途別(獣医用ワクチンアジュバント(研究、商業)、ヒト用ワクチンアジュバント(研究、商業))
・ワクチンアジュバントの米国市場規模2015-2020
・ワクチンアジュバントのヨーロッパ市場規模2015-2020
・ワクチンアジュバントの中国市場規模2015-2020
・ワクチンアジュバントの日本市場規模2015-2020
・ワクチンアジュバントの東南アジア市場規模2015-2020
・ワクチンアジュバントのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ワクチンアジュバントの製造コスト分析
・販売チャネル、流通業者、顧客
・ワクチンアジュバントの市場動向・機会・課題
・調査の結論

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.
The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.

Market Analysis and Insights: Global Vaccine Adjuvants Market
The global Vaccine Adjuvants market size is projected to reach US$ 1364.7 million by 2026, from US$ 762 million in 2020, at a CAGR of 10.2% during 2021-2026.

Global Vaccine Adjuvants Scope and Market Size
The global Vaccine Adjuvants market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Vaccine Adjuvants market is segmented into
Oral
Subcutaneous
Intramuscular
Others

Segment by Application, the Vaccine Adjuvants market is segmented into
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)

The Vaccine Adjuvants market is analysed and market size information is provided by regions (countries). Segment by Application, the Vaccine Adjuvants market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Vaccine Adjuvants Market Share Analysis
Vaccine Adjuvants market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vaccine Adjuvants business, the date to enter into the Vaccine Adjuvants market, Vaccine Adjuvants product introduction, recent developments, etc.

The major vendors covered:
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

レポート目次

1 Vaccine Adjuvants Market Overview
1.1 Vaccine Adjuvants Product Scope
1.2 Vaccine Adjuvants Segment by Type
1.2.1 Global Vaccine Adjuvants Sales by Type (2020-2026)
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Vaccine Adjuvants Segment by Application
1.3.1 Global Vaccine Adjuvants Sales Comparison by Application (2020-2026)
1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Vaccine Adjuvants Market Estimates and Forecasts (2015-2026)
1.4.1 Global Vaccine Adjuvants Sales Growth Rate (2015-2026)
1.4.2 Global Vaccine Adjuvants Revenue and Growth Rate (2015-2026)
1.4.3 Global Vaccine Adjuvants Price Trends (2015-2026)

2 Vaccine Adjuvants Estimate and Forecast by Region
2.1 Global Vaccine Adjuvants Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Vaccine Adjuvants Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Vaccine Adjuvants Sales Market Share by Region (2015-2020)
2.2.2 Global Vaccine Adjuvants Revenue Market Share by Region (2015-2020)
2.3 Global Vaccine Adjuvants Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Vaccine Adjuvants Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Vaccine Adjuvants Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Vaccine Adjuvants Estimates and Projections (2015-2026)
2.4.2 Europe Vaccine Adjuvants Estimates and Projections (2015-2026)
2.4.3 China Vaccine Adjuvants Estimates and Projections (2015-2026)
2.4.4 Japan Vaccine Adjuvants Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Vaccine Adjuvants Estimates and Projections (2015-2026)
2.4.6 India Vaccine Adjuvants Estimates and Projections (2015-2026)
3 Global Vaccine Adjuvants Competition Landscape by Players
3.1 Global Top Vaccine Adjuvants Players by Sales (2015-2020)
3.2 Global Top Vaccine Adjuvants Players by Revenue (2015-2020)
3.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Adjuvants as of 2019)
3.4 Global Vaccine Adjuvants Average Price by Company (2015-2020)
3.5 Manufacturers Vaccine Adjuvants Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Vaccine Adjuvants Players (Opinion Leaders)
4 Global Vaccine Adjuvants Market Size by Type
4.1 Global Vaccine Adjuvants Historic Market Review by Type (2015-2020)
4.1.1 Global Vaccine Adjuvants Sales Market Share by Type (2015-2020)
4.1.2 Global Vaccine Adjuvants Revenue Market Share by Type (2015-2020)
4.1.3 Global Vaccine Adjuvants Price by Type (2015-2020)
4.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Vaccine Adjuvants Sales Forecast by Type (2021-2026)
4.2.2 Global Vaccine Adjuvants Revenue Forecast by Type (2021-2026)
4.2.3 Global Vaccine Adjuvants Price Forecast by Type (2021-2026)
5 Global Vaccine Adjuvants Market Size by Application
5.1 Global Vaccine Adjuvants Historic Market Review by Application (2015-2020)
5.1.1 Global Vaccine Adjuvants Sales Market Share by Application (2015-2020)
5.1.2 Global Vaccine Adjuvants Revenue Market Share by Application (2015-2020)
5.1.3 Global Vaccine Adjuvants Price by Application (2015-2020)
5.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Vaccine Adjuvants Sales Forecast by Application (2021-2026)
5.2.2 Global Vaccine Adjuvants Revenue Forecast by Application (2021-2026)
5.2.3 Global Vaccine Adjuvants Price Forecast by Application (2021-2026)

6 United States Vaccine Adjuvants Market Facts & Figures
6.1 United States Vaccine Adjuvants Sales Market Share by Company (2015-2020)
6.2 United States Vaccine Adjuvants Sales Market Share by Type (2015-2020)
6.3 United States Vaccine Adjuvants Sales Market Share by Application (2015-2020)

7 Europe Vaccine Adjuvants Market Facts & Figures
7.1 Europe Vaccine Adjuvants Sales Market Share by Company (2015-2020)
7.2 Europe Vaccine Adjuvants Sales Market Share by Type (2015-2020)
7.3 Europe Vaccine Adjuvants Sales Market Share by Application (2015-2020)

8 China Vaccine Adjuvants Market Facts & Figures
8.1 China Vaccine Adjuvants Sales Market Share by Company (2015-2020)
8.2 China Vaccine Adjuvants Sales Market Share by Type (2015-2020)
8.3 China Vaccine Adjuvants Sales Market Share by Application (2015-2020)

9 Japan Vaccine Adjuvants Market Facts & Figures
9.1 Japan Vaccine Adjuvants Sales Market Share by Company (3015-3030)
9.2 Japan Vaccine Adjuvants Sales Market Share by Type (2015-2020)
9.3 Japan Vaccine Adjuvants Sales Market Share by Application (2015-2020)

10 Southeast Asia Vaccine Adjuvants Market Facts & Figures
10.1 Southeast Asia Vaccine Adjuvants Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Vaccine Adjuvants Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Vaccine Adjuvants Sales Market Share by Application (2015-2020)

11 India Vaccine Adjuvants Market Facts & Figures
11.1 India Vaccine Adjuvants Sales Market Share by Company (2015-2020)
11.2 India Vaccine Adjuvants Sales Market Share by Type (2015-2020)
11.3 India Vaccine Adjuvants Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Vaccine Adjuvants Business
12.1 SEPPIC
12.1.1 SEPPIC Corporation Information
12.1.2 SEPPIC Business Overview
12.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.1.4 SEPPIC Vaccine Adjuvants Products Offered
12.1.5 SEPPIC Recent Development
12.2 SDA BIO
12.2.1 SDA BIO Corporation Information
12.2.2 SDA BIO Business Overview
12.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.2.4 SDA BIO Vaccine Adjuvants Products Offered
12.2.5 SDA BIO Recent Development
12.3 Croda International Plc
12.3.1 Croda International Plc Corporation Information
12.3.2 Croda International Plc Business Overview
12.3.3 Croda International Plc Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Croda International Plc Vaccine Adjuvants Products Offered
12.3.5 Croda International Plc Recent Development
12.4 SPI Pharma
12.4.1 SPI Pharma Corporation Information
12.4.2 SPI Pharma Business Overview
12.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.4.4 SPI Pharma Vaccine Adjuvants Products Offered
12.4.5 SPI Pharma Recent Development
12.5 Phibro Animal Health Corporation
12.5.1 Phibro Animal Health Corporation Corporation Information
12.5.2 Phibro Animal Health Corporation Business Overview
12.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Phibro Animal Health Corporation Vaccine Adjuvants Products Offered
12.5.5 Phibro Animal Health Corporation Recent Development
12.6 Tj Kaiwei
12.6.1 Tj Kaiwei Corporation Information
12.6.2 Tj Kaiwei Business Overview
12.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Tj Kaiwei Vaccine Adjuvants Products Offered
12.6.5 Tj Kaiwei Recent Development
12.7 Novavax
12.7.1 Novavax Corporation Information
12.7.2 Novavax Business Overview
12.7.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novavax Vaccine Adjuvants Products Offered
12.7.5 Novavax Recent Development
12.8 Zhuoyue
12.8.1 Zhuoyue Corporation Information
12.8.2 Zhuoyue Business Overview
12.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Zhuoyue Vaccine Adjuvants Products Offered
12.8.5 Zhuoyue Recent Development
12.9 Aphios
12.9.1 Aphios Corporation Information
12.9.2 Aphios Business Overview
12.9.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Aphios Vaccine Adjuvants Products Offered
12.9.5 Aphios Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.10.4 GSK Vaccine Adjuvants Products Offered
12.10.5 GSK Recent Development
12.11 CSL Limited
12.11.1 CSL Limited Corporation Information
12.11.2 CSL Limited Business Overview
12.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.11.4 CSL Limited Vaccine Adjuvants Products Offered
12.11.5 CSL Limited Recent Development
12.12 Brenntag Biosector
12.12.1 Brenntag Biosector Corporation Information
12.12.2 Brenntag Biosector Business Overview
12.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Brenntag Biosector Vaccine Adjuvants Products Offered
12.12.5 Brenntag Biosector Recent Development
12.13 SEPPIC
12.13.1 SEPPIC Corporation Information
12.13.2 SEPPIC Business Overview
12.13.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.13.4 SEPPIC Vaccine Adjuvants Products Offered
12.13.5 SEPPIC Recent Development
12.14 SPI Pharma
12.14.1 SPI Pharma Corporation Information
12.14.2 SPI Pharma Business Overview
12.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.14.4 SPI Pharma Vaccine Adjuvants Products Offered
12.14.5 SPI Pharma Recent Development
12.15 Novavax
12.15.1 Novavax Corporation Information
12.15.2 Novavax Business Overview
12.15.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Novavax Vaccine Adjuvants Products Offered
12.15.5 Novavax Recent Development
12.16 Avanti Polar Lipids
12.16.1 Avanti Polar Lipids Corporation Information
12.16.2 Avanti Polar Lipids Business Overview
12.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Avanti Polar Lipids Vaccine Adjuvants Products Offered
12.16.5 Avanti Polar Lipids Recent Development
12.17 Aphios
12.17.1 Aphios Corporation Information
12.17.2 Aphios Business Overview
12.17.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Aphios Vaccine Adjuvants Products Offered
12.17.5 Aphios Recent Development

13 Vaccine Adjuvants Manufacturing Cost Analysis
13.1 Vaccine Adjuvants Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vaccine Adjuvants
13.4 Vaccine Adjuvants Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vaccine Adjuvants Distributors List
14.3 Vaccine Adjuvants Customers

15 Market Dynamics
15.1 Vaccine Adjuvants Market Trends
15.2 Vaccine Adjuvants Opportunities and Drivers
15.3 Vaccine Adjuvants Market Challenges
15.4 Vaccine Adjuvants Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Vaccine Adjuvants Sales (Kg) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Vaccine Adjuvants Sales (Kg) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Vaccine Adjuvants Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Vaccine Adjuvants Sales (Kg) by Region (2015-2020)
Table 5. Global Vaccine Adjuvants Sales Market Share by Region (2015-2020)
Table 6. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Vaccine Adjuvants Revenue Share by Region (2015-2020)
Table 8. Global Vaccine Adjuvants Sales (Kg) Forecast by Region (2021-2026)
Table 9. Global Vaccine Adjuvants Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Vaccine Adjuvants Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Vaccine Adjuvants Revenue Share Forecast by Region (2021-2026)
Table 12. Global Vaccine Adjuvants (Kg) of Key Companies (2015-2020)
Table 13. Global Vaccine Adjuvants Sales Share by Company (2015-2020)
Table 14. Global Vaccine Adjuvants Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Vaccine Adjuvants Revenue Share by Company (2015-2020)
Table 16. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Adjuvants as of 2019)
Table 17. Global Vaccine Adjuvants Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Vaccine Adjuvants Manufacturing Sites and Area Served
Table 19. Manufacturers Vaccine Adjuvants Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Vaccine Adjuvants Players
Table 22. Global Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 23. Global Vaccine Adjuvants Sales Share by Type (2015-2020)
Table 24. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Vaccine Adjuvants Price (Kg) by Type (2015-2020)
Table 26. Global Vaccine Adjuvants Sales Share by Type (2021-2026)
Table 27. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Vaccine Adjuvants Revenue Share by Type (2021-2026)
Table 29. Global Vaccine Adjuvants Price (Kg) by Type (2021-2026)
Table 30. Global Vaccine Adjuvants Sales (Kg) by Application (2015-2020)
Table 31. Global Vaccine Adjuvants Sales Share by Application (2015-2020)
Table 32. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Vaccine Adjuvants Price (Kg) by Application (2015-2020)
Table 34. Global Vaccine Adjuvants Sales (Kg) by Application (2021-2026)
Table 35. Global Vaccine Adjuvants Sales Share by Application (2021-2026)
Table 36. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Vaccine Adjuvants Revenue Share by Application (2021-2026)
Table 38. Global Vaccine Adjuvants Price (Kg) by Application (2021-2026)
Table 39. United States Vaccine Adjuvants Sales (Kg) by Company (2015-2020)
Table 40. United States Vaccine Adjuvants Sales Market Share by Company (2015-2020)
Table 41. United States Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 42. United States Vaccine Adjuvants Sales Market Share by Type (2015-2020)
Table 43. United States Vaccine Adjuvants Sales (Kg) by Application (2015-2020)
Table 44. United States Vaccine Adjuvants Sales Market Share by Application (2015-2020)
Table 45. Europe Vaccine Adjuvants Sales (Kg) by Company (2015-2020)
Table 46. Europe Vaccine Adjuvants Sales Market Share by Company (2015-2020)
Table 47. Europe Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 48. Europe Vaccine Adjuvants Sales Market Share by Type (2015-2020)
Table 49. Europe Vaccine Adjuvants Sales (Kg) by Application (2015-2020)
Table 50. Europe Vaccine Adjuvants Sales Market Share by Type (2015-2020)
Table 51. China Vaccine Adjuvants Sales (Kg) by Company (2015-2020)
Table 52. China Vaccine Adjuvants Sales Market Share by Company (2015-2020)
Table 53. China Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 54. China Vaccine Adjuvants Sales Market Share by Type (2015-2020)
Table 55. China Vaccine Adjuvants Sales (Kg) by Application (2015-2020)
Table 56. China Vaccine Adjuvants Sales Market Share by Application (2015-2020)
Table 57. Japan Vaccine Adjuvants Sales (Kg) by Company (2015-2020)
Table 58. Japan Vaccine Adjuvants Sales Market Share by Company (2015-2020)
Table 59. Japan Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 60. Japan Vaccine Adjuvants Sales Market Share by Type (2015-2020)
Table 61. Japan Vaccine Adjuvants Sales (Kg) by Application (2015-2020)
Table 62. Japan Vaccine Adjuvants Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Vaccine Adjuvants Sales (Kg) by Company (2015-2020)
Table 64. Southeast Asia Vaccine Adjuvants Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 66. Southeast Asia Vaccine Adjuvants Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 68. Southeast Asia Vaccine Adjuvants Sales Market Share by Application (2015-2020)
Table 69. India Vaccine Adjuvants Sales (Kg) by Company (2015-2020)
Table 70. India Vaccine Adjuvants Sales Market Share by Company (2015-2020)
Table 71. India Vaccine Adjuvants Sales (Kg) by Type (2015-2020)
Table 72. India Vaccine Adjuvants Sales Market Share by Type (2015-2020)
Table 73. India Vaccine Adjuvants Sales (Kg) by Application (2015-2020)
Table 74. India Vaccine Adjuvants Sales Market Share by Application (2015-2020)
Table 75. SEPPIC Corporation Information
Table 76. SEPPIC Description and Business Overview
Table 77. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. SEPPIC Vaccine Adjuvants Product
Table 79. SEPPIC Recent Development
Table 80. SDA BIO Corporation Information
Table 81. SDA BIO Description and Business Overview
Table 82. SDA BIO Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. SDA BIO Vaccine Adjuvants Product
Table 84. SDA BIO Recent Development
Table 85. Croda International Plc Corporation Information
Table 86. Croda International Plc Description and Business Overview
Table 87. Croda International Plc Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Croda International Plc Vaccine Adjuvants Product
Table 89. Croda International Plc Recent Development
Table 90. SPI Pharma Corporation Information
Table 91. SPI Pharma Description and Business Overview
Table 92. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. SPI Pharma Vaccine Adjuvants Product
Table 94. SPI Pharma Recent Development
Table 95. Phibro Animal Health Corporation Corporation Information
Table 96. Phibro Animal Health Corporation Description and Business Overview
Table 97. Phibro Animal Health Corporation Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Phibro Animal Health Corporation Vaccine Adjuvants Product
Table 99. Phibro Animal Health Corporation Recent Development
Table 100. Tj Kaiwei Corporation Information
Table 101. Tj Kaiwei Description and Business Overview
Table 102. Tj Kaiwei Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Tj Kaiwei Vaccine Adjuvants Product
Table 104. Tj Kaiwei Recent Development
Table 105. Novavax Corporation Information
Table 106. Novavax Description and Business Overview
Table 107. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Novavax Vaccine Adjuvants Product
Table 109. Novavax Recent Development
Table 110. Zhuoyue Corporation Information
Table 111. Zhuoyue Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Zhuoyue Description and Business Overview
Table 113. Zhuoyue Vaccine Adjuvants Product
Table 114. Zhuoyue Recent Development
Table 115. Aphios Corporation Information
Table 116. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Aphios Description and Business Overview
Table 118. Aphios Vaccine Adjuvants Product
Table 119. Aphios Recent Development
Table 120. GSK Corporation Information
Table 121. GSK Description and Business Overview
Table 122. GSK Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. GSK Vaccine Adjuvants Product
Table 124. GSK Recent Development
Table 125. CSL Limited Corporation Information
Table 126. CSL Limited Description and Business Overview
Table 127. CSL Limited Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. CSL Limited Vaccine Adjuvants Product
Table 129. CSL Limited Recent Development
Table 130. Brenntag Biosector Corporation Information
Table 131. Brenntag Biosector Description and Business Overview
Table 132. Brenntag Biosector Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Brenntag Biosector Vaccine Adjuvants Product
Table 134. Brenntag Biosector Recent Development
Table 135. SEPPIC Corporation Information
Table 136. SEPPIC Description and Business Overview
Table 137. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. SEPPIC Vaccine Adjuvants Product
Table 139. SEPPIC Recent Development
Table 140. SPI Pharma Corporation Information
Table 141. SPI Pharma Description and Business Overview
Table 142. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. SPI Pharma Vaccine Adjuvants Product
Table 144. SPI Pharma Recent Development
Table 145. Novavax Corporation Information
Table 146. Novavax Description and Business Overview
Table 147. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. Novavax Vaccine Adjuvants Product
Table 149. Novavax Recent Development
Table 150. Avanti Polar Lipids Corporation Information
Table 151. Avanti Polar Lipids Description and Business Overview
Table 152. Avanti Polar Lipids Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 153. Avanti Polar Lipids Vaccine Adjuvants Product
Table 154. Avanti Polar Lipids Recent Development
Table 155. Aphios Corporation Information
Table 156. Aphios Description and Business Overview
Table 157. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 158. Aphios Vaccine Adjuvants Product
Table 159. Aphios Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Vaccine Adjuvants Distributors List
Table 163. Vaccine Adjuvants Customers List
Table 164. Vaccine Adjuvants Market Key Trends
Table 165. Vaccine Adjuvants Key Opportunities and Drivers
Table 166. Vaccine Adjuvants Market Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vaccine Adjuvants Market Share by Application in 2020 & 2026
Figure 6. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Examples
Figure 7. Human Vaccine Adjuvants (Research Applications, Commercial Applications) Examples
Figure 8. Global Vaccine Adjuvants Sales (Kg) Growth Rate (2015-2026)
Figure 9. Global Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Vaccine Adjuvants Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Vaccine Adjuvants Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Vaccine Adjuvants Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Vaccine Adjuvants Sales (Kg) Growth Rate (2015-2026)
Figure 15. Europe Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Vaccine Adjuvants Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Vaccine Adjuvants Players Market Share by Revenue in Vaccine Adjuvants 2015 & 2019
Figure 26. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Vaccine Adjuvants Revenue Share by Type (2015-2020)
Figure 28. Global Vaccine Adjuvants Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Vaccine Adjuvants Revenue Share by Application (2015-2020)
Figure 30. Global Vaccine Adjuvants Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Vaccine Adjuvants Sales Market Share by Type in 2019
Figure 32. United States Vaccine Adjuvants Sales Market Share by Type in 2019
Figure 33. Europe Vaccine Adjuvants Sales Market Share by Company in 2019
Figure 34. Europe Vaccine Adjuvants Sales Market Share by Type in 2019
Figure 35. Europe Vaccine Adjuvants Sales Market Share by Application in 2019
Figure 36. China Vaccine Adjuvants Sales Market Share by Company in 2019
Figure 37. China Vaccine Adjuvants Sales Market Share by Type in 2019
Figure 38. China Vaccine Adjuvants Sales Market Share by Application in 2019
Figure 39. Japan Vaccine Adjuvants Sales Market Share by Company in 2019
Figure 40. Japan Vaccine Adjuvants Sales Market Share by Type in 2019
Figure 41. Japan Vaccine Adjuvants Sales Market Share by Application in 2019
Figure 42. Southeast Asia Vaccine Adjuvants Sales Market Share by Company in 2019
Figure 43. Southeast Asia Vaccine Adjuvants Sales Market Share by Type in 2019
Figure 44. Southeast Asia Vaccine Adjuvants Sales Market Share by Application in 2019
Figure 45. India Vaccine Adjuvants Sales Market Share by Company in 2019
Figure 46. India Vaccine Adjuvants Sales Market Share by Type in 2019
Figure 47. India Vaccine Adjuvants Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Vaccine Adjuvants
Figure 50. Manufacturing Process Analysis of Vaccine Adjuvants
Figure 51. Vaccine Adjuvants Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed



• 英文レポート名:Global Vaccine Adjuvants Sales Market Report 2020
• 日本語訳:ワクチンアジュバントのグローバル販売市場 2020年
• レポートコード:MRC2102QY15834お問い合わせ(見積依頼・ご注文・質問)